Skip to main content Skip to main navigation menu Skip to site footer
Page Header Logo
  • Home
  • About
    • About the Journal
    • Aims & Scope
    • Editorial Board
    • Contact
  • Current
  • Archives
  • Indexing & Abstracting
  • For Authors
    • Author Guidelines
    • Peer Review Policy
    • Ethical Consideration
    • Ethics & Integrity
    • Publication Fees
    • Submissions
Search
  • Register
  • Login
  1. Home /
  2. Search

Advanced filters
High-expression of V-domain Imuunoglobulin Suppressor of T-cell Activation (VISTA) Is Correlated with Advanced Pathological Features in Patients with Pancreatic Ductal Adenocarcinoma
Hamid Nickho, Reza Falak, Fereshteh Rezagholizadeh, Majid Khoshmirsafa, Mohammad Taghi Joghataei, Shabnam Mollazadeh Ghomi, Elaheh Safari
Published: 2024-05-27
Astragalus Polysaccharide Mediates Immunomodulatory Effects on Crosstalk between Human Peripheral Blood Mononuclear Cells and Ovarian Cancer Cell Line
Elham Shokati, Morteza Motallebnezhad, Elaheh Safari
Published: 2023-04-30
Exploring the Therapeutic Potential of Fluorinated CXCR4 Inhibitor A1: Insights from Breast Cancer In Vitro Investigations
Ali Rahimi, Hossein Khorramdelazad, Ali Darehkordi, Gholamhossein Hassanshahi, Majid Khoshmirsafa, Milad Karimi, Reza Falak, Elaheh Safari
Published: 2025-09-16
1 - 3 of 3 items


2024 Impact Factor: 1.2
2024 CiteScore: 2.4


pISSN: 1735-1502
eISSN: 1735-5249


Chairman:
Mostafa Moin, M.D. 

Editors-in-Chief:
Masoud Movahedi, M.D.

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).

2.4
2024CiteScore
 
 
27th percentile
Powered by  Scopus

 

SCImago Journal & Country Rank

Make a Submission
Information
  • Publication Fee
  • For Readers
  • For Authors
  • For Librarians
Iranian Journal of Allergy, Asthma and Immunology (Bimonthly), pISSN: 1735-1502, eISSN: 1735-5249
Tehran University of Medical Sciences, Tehran, Iran.

All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.